It is a real estate and construction private limited company based in New Delhi, Delhi, India, established in 1998.
1998 | New Delhi, Delhi, India | ActiveBr Biologics Private Limited, a active private limited company, was established on 26 February 1998 in New Delhi, Delhi, India. Engaging in real estate marketing & sales within the real estate and construction sector, it holds CIN: U74220DL1998PTC092443. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.25 Cr and a paid-up capital of ₹2.25 Cr.
It upholds a compliant status. Its leadership includes Surinder Pal Chawla (Director), Bhushan Kumar Chawla (Director). Past directors included Surinder Pal Chawla, Bhushan Kumar Chawla, Pankaj Chawla. It holds no open charges and ₹0.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 416, Ground Floor, Bhera Enclave, Paschim Vihar,, New Delhi, Delhi, 110087.
U74220DL1998PTC092443
092443
26 February 1998
₹2.25 Cr
₹2.25 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Br Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Pal Chawla | Director | 08 Feb 2021 | Current |
| Bhushan Kumar Chawla | Director | 01 Feb 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 01 Feb 2021 | Past |
| Pramod Abcsdd | Director | 08 Feb 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Br Biologics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 407.57% increase. The company also saw a substantial improvement in profitability, with a 54.07% increase in profit. The company's net worth moved up by a moderate rise of 1.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Br Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Nov 2003 | State Bank Of Mysoore | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Br Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Br Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Br Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Br Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Br Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge registered on 27 Nov 2003 via Charge ID 90055114 with State Bank Of Mysoore was fully satisfied on 07 Jul 2021. was recorded as a recent event.
Progress on Surinder Pal Chawla was appointed as a Director was appointed as a Director on 08 Feb 2021 & has been associated with this company since 4 years 9 months . was documented.
Bhushan Kumar Chawla was appointed as a Director was appointed as a Director on 01 Feb 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
The activity A charge with State Bank Of Mysoore of Rs. 0.05 Cr registered on 27 Nov 2003 with Charge ID 90055114 was modified on 08 Mar 2004. was completed.
The CIN of Br Biologics Private Limited is U74220DL1998PTC092443.
Br Biologics Private Limited is headquartered at 416, Ground Floor, Bhera Enclave, Paschim Vihar,, New Delhi, Delhi, 110087.
Br Biologics Private Limited was incorporated on 26 February 1998.
The current directors of Br Biologics Private Limited are
The primary industry of Br Biologics Private Limited is Real Estate And Construction.
Br Biologics Private Limited is unlisted.
The authorized capital of Br Biologics Private Limited is ₹2.25 Cr, and the paid-up capital is ₹2.25 Cr.
The compliance status of Br Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX